vs
Side-by-side financial comparison of CENTRAL PACIFIC FINANCIAL CORP (CPF) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $72.9M, roughly 1.7× CENTRAL PACIFIC FINANCIAL CORP). CENTRAL PACIFIC FINANCIAL CORP runs the higher net margin — 28.4% vs 3.3%, a 25.1% gap on every dollar of revenue. On growth, CENTRAL PACIFIC FINANCIAL CORP posted the faster year-over-year revenue change (6.0% vs 4.7%). Over the past eight quarters, CENTRAL PACIFIC FINANCIAL CORP's revenue compounded faster (6.7% CAGR vs 5.6%).
Central Pacific Bank (CPB) is an American regional commercial bank located throughout the state of Hawaii.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
CPF vs NATR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $72.9M | $123.8M |
| Net Profit | $20.7M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | — | 4.3% |
| Net Margin | 28.4% | 3.3% |
| Revenue YoY | 6.0% | 4.7% |
| Net Profit YoY | 16.7% | 1379.4% |
| EPS (diluted) | $0.78 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $76.3M | $123.8M | ||
| Q3 25 | $74.8M | $128.3M | ||
| Q2 25 | $72.8M | $114.8M | ||
| Q1 25 | $68.8M | $113.2M | ||
| Q4 24 | $58.4M | $118.2M | ||
| Q3 24 | $66.6M | $114.6M | ||
| Q2 24 | $64.0M | $110.6M |
| Q1 26 | $20.7M | — | ||
| Q4 25 | $22.9M | $4.1M | ||
| Q3 25 | $18.6M | $5.3M | ||
| Q2 25 | $18.3M | $5.3M | ||
| Q1 25 | $17.8M | $4.7M | ||
| Q4 24 | $11.3M | $-321.0K | ||
| Q3 24 | $13.3M | $4.3M | ||
| Q2 24 | $15.8M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% |
| Q1 26 | — | — | ||
| Q4 25 | 37.0% | 4.3% | ||
| Q3 25 | 31.6% | 7.0% | ||
| Q2 25 | 32.8% | 3.7% | ||
| Q1 25 | 32.8% | 5.4% | ||
| Q4 24 | 23.0% | 3.8% | ||
| Q3 24 | 25.6% | 4.6% | ||
| Q2 24 | 32.2% | 5.1% |
| Q1 26 | 28.4% | — | ||
| Q4 25 | 30.0% | 3.3% | ||
| Q3 25 | 24.8% | 4.2% | ||
| Q2 25 | 25.1% | 4.6% | ||
| Q1 25 | 25.8% | 4.2% | ||
| Q4 24 | 19.4% | -0.3% | ||
| Q3 24 | 20.0% | 3.8% | ||
| Q2 24 | 24.7% | 1.2% |
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.85 | $0.23 | ||
| Q3 25 | $0.69 | $0.30 | ||
| Q2 25 | $0.67 | $0.28 | ||
| Q1 25 | $0.65 | $0.25 | ||
| Q4 24 | $0.42 | $-0.02 | ||
| Q3 24 | $0.49 | $0.23 | ||
| Q2 24 | $0.58 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $93.9M |
| Total DebtLower is stronger | $76.5M | — |
| Stockholders' EquityBook value | $593.9M | $161.6M |
| Total Assets | $7.5B | $261.1M |
| Debt / EquityLower = less leverage | 0.13× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $93.9M | ||
| Q3 25 | — | $95.6M | ||
| Q2 25 | — | $81.3M | ||
| Q1 25 | — | $86.5M | ||
| Q4 24 | — | $84.7M | ||
| Q3 24 | — | $78.7M | ||
| Q2 24 | — | $68.7M |
| Q1 26 | $76.5M | — | ||
| Q4 25 | $76.5M | — | ||
| Q3 25 | $131.5M | — | ||
| Q2 25 | $131.5M | — | ||
| Q1 25 | $131.4M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $156.3M | — | ||
| Q2 24 | $156.2M | — |
| Q1 26 | $593.9M | — | ||
| Q4 25 | $592.6M | $161.6M | ||
| Q3 25 | $588.1M | $166.7M | ||
| Q2 25 | $568.9M | $163.7M | ||
| Q1 25 | $557.4M | $167.1M | ||
| Q4 24 | $538.4M | $161.0M | ||
| Q3 24 | $543.7M | $162.6M | ||
| Q2 24 | $518.6M | $156.4M |
| Q1 26 | $7.5B | — | ||
| Q4 25 | $7.4B | $261.1M | ||
| Q3 25 | $7.4B | $264.8M | ||
| Q2 25 | $7.4B | $254.9M | ||
| Q1 25 | $7.4B | $252.7M | ||
| Q4 24 | $7.5B | $240.9M | ||
| Q3 24 | $7.4B | $245.3M | ||
| Q2 24 | $7.4B | $235.8M |
| Q1 26 | 0.13× | — | ||
| Q4 25 | 0.13× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.30× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $9.9M |
| Free Cash FlowOCF − Capex | — | $7.6M |
| FCF MarginFCF / Revenue | — | 6.1% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $97.5M | $9.9M | ||
| Q3 25 | $22.2M | $18.5M | ||
| Q2 25 | $34.3M | $4.3M | ||
| Q1 25 | $20.4M | $2.6M | ||
| Q4 24 | $90.5M | $12.2M | ||
| Q3 24 | $21.3M | $9.6M | ||
| Q2 24 | $25.9M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | $92.3M | $7.6M | ||
| Q3 25 | $21.4M | $16.8M | ||
| Q2 25 | $32.3M | $3.0M | ||
| Q1 25 | $19.6M | $1.5M | ||
| Q4 24 | $75.4M | $10.0M | ||
| Q3 24 | $15.6M | $7.9M | ||
| Q2 24 | $21.3M | $-2.0M |
| Q1 26 | — | — | ||
| Q4 25 | 121.0% | 6.1% | ||
| Q3 25 | 28.6% | 13.1% | ||
| Q2 25 | 44.3% | 2.6% | ||
| Q1 25 | 28.4% | 1.3% | ||
| Q4 24 | 129.2% | 8.5% | ||
| Q3 24 | 23.5% | 6.9% | ||
| Q2 24 | 33.2% | -1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 1.9% | ||
| Q3 25 | 1.2% | 1.3% | ||
| Q2 25 | 2.7% | 1.2% | ||
| Q1 25 | 1.3% | 1.0% | ||
| Q4 24 | 25.8% | 1.9% | ||
| Q3 24 | 8.5% | 1.5% | ||
| Q2 24 | 7.3% | 3.0% |
| Q1 26 | — | — | ||
| Q4 25 | 4.26× | 2.41× | ||
| Q3 25 | 1.20× | 3.46× | ||
| Q2 25 | 1.88× | 0.81× | ||
| Q1 25 | 1.15× | 0.55× | ||
| Q4 24 | 7.98× | — | ||
| Q3 24 | 1.60× | 2.21× | ||
| Q2 24 | 1.64× | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CPF
Segment breakdown not available.
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
